Assignee
MESHABERASE LLC
US·2 granted patents·4 pending applications·0 citations·filing 2017–2023
Top patents by PatentIndex Score
6 records- 0177US2024082177A1Use of cysteamine and derivatives thereof to suppress tumor metastasesMESHABERASE LLC·Filed 2023·Application pending·0 cites
- 0271US11052057B2Use of cysteamine and derivatives thereof to suppress tumor metastasesMESHABERASE LLC·Filed 2019·Granted Jul 6, 2021·0 cites·20 claims
- 0369US11844769B2Use of cysteamine and derivatives thereof to suppress tumor metastasesMESHABERASE LLC·Filed 2021·Granted Dec 19, 2023·0 cites·13 claims
- 0466US2019142769A1Use of cysteamine and derivatives thereof to suppress tumor metastasesMESHABERASE LLC·Filed 2019·Application pending·0 cites
- 0561US2018042870A1Use of cysteamine and derivatives thereof to suppress tumor metastasesMESHABERASE LLC·Filed 2017·Application pending·0 cites
- 0650US2021196652A1Use of cysteamine and derivatives thereof to treat dysfunctional tear syndrome (dts)MESHABERASE LLC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →